Coronavirus disease (COVID-19) is an infectious disease caused by the coronavirus SARS-CoV-2. Here we have collected APR news related to the COVID-19 pandemic, vaccination efforts and emerging treatments.
Thursday, August 05, 2021
MyMD Pharmaceuticals Inc., a clinical-stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms, announced that a human cell research ...
read more
Thursday, August 05, 2021
Akston Biosciences Corporation, a developer of new classes of biologic therapeutics, announced that the first participants have been dosed in a Phase II open-label trial of AKS-452, its protein ...
read more
Ortho Clinical Diagnostics, one of the world's largest pure-play in vitro diagnostics companies, announced its qualitative COVID-19 Total N antibody test received US FDA EUA. This new antibody test is...
read more
Akston Biosciences Corporation, a developer of new classes of biologic therapeutics, announced that the first participants have been dosed in a Phase II open-label trial of AKS-452, its protein ...
read more
Bavarian Nordic A/S reported initial results from the first-in-human trial of ABNCoV2, led by the PREVENT-nCoV consortium. The Phase 1/2 dose-escalation trial enrolled 45 healthy SARS-CoV-2-naïve ...
read more
Thursday, August 12, 2021
Sen-Jam, a life-science startup led by Registered Pharmacist Jacqueline Iversen, has partnered with researcher Ashley St. John PhD of the Duke-NUS Medical School in Singapore, to trial a novel ...
read more
Thermo Fisher Scientific, the world leader in serving science, today announced that the U.S. Food and Drug Administration (FDA) has granted emergency use authorization (EUA) for the TaqPath COVID-19 ...
read more
Moderna Inc., a biotechnology company pioneering mRNA therapeutics and vaccines, announced a revised supply agreement with the Government of Canada for up to 105 million doses of Moderna’s COVID-19 ...
read more
Biotage is one of the few companies offering a complete solution and ready to go off-the-shelf products for the purification of large-scale lipids, used in mRNA vaccine development and production. ...
read more
Positive high-level results from the PROVENT Phase III pre-exposure prophylaxis trial showed AstraZeneca's AZD7442 achieved a statistically significant reduction in the incidence of symptomatic COVID-...
read more
Regeneron Pharmaceuticals Inc. announced that the United Kingdom's (UK) Medicines and Healthcare products Regulatory Agency (MHRA) has granted Conditional Marketing Authorization (CMA) for the ...
read more
Pfizer and BioNTech announced the FDA approval of the Biologics License Application (BLA) for COMIRNATY® (COVID-19 Vaccine, mRNA) to prevent COVID-19 in individuals 16 years of age and older. ...
read more
Wednesday, August 25, 2021
Johnson & Johnson announced data supporting the use of its COVID-19 vaccine as a booster shot for people previously vaccinated with the single-shot Johnson & Johnson vaccine. In July, the Company ...
read more
Thursday, August 26, 2021
RedHill Biopharma Ltd, a specialty biopharmaceutical company, announced preliminary results of a new preclinical study showing strong inhibition by opaganib (ABC294640)of Delta variant replication ...
read more
Thursday, August 26, 2021
Pfizer Inc. and BioNTech SE announced the initiation of a supplemental Biologics License Application (sBLA) to the FDA for approval of a booster (third) dose of COMIRNATY® (COVID-19 vaccine, mRNA) to ...
read more